The deletion of TrkA, the high-affinity receptor of a major cholinergic regulator, also showed no significant behavioral abnormality even though the presence of decreased cholinergic terminals in the targeted area [43] while cognitive decline in a similar genetic TrkA deletion model was reported [44]. The gene discussed is NTRK1; the disease is Mental deterioration.